EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Net Debt Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual net debt in 2023 was 53.21 Billion KRW , up 25.73% from previous year.
EASY BIO,Inc.'s latest quarterly net debt in 2024 Q1 was 98.9 Billion KRW , up 85.88% from previous quarter.
EASY BIO,Inc. reported annual net debt of 42.32 Billion KRW in 2022, up 38.69% from previous year.
EASY BIO,Inc. reported annual net debt of 30.51 Billion KRW in 2021, up 81.74% from previous year.
EASY BIO,Inc. reported quarterly net debt of 169.21 Billion KRW for 2024 Q2, up 71.08% from previous quarter.
EASY BIO,Inc. reported quarterly net debt of 51.45 Billion KRW for 2023 Q2, down -10.4% from previous quarter.

Annual Net Debt Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Net Debt of EASY BIO,Inc. (2023 - 2020)

Year	Net Debt	Net Debt Growth
2023	53.21 Billion KRW	25.73%
2022	42.32 Billion KRW	38.69%
2021	30.51 Billion KRW	81.74%
2020	16.79 Billion KRW	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	98.9 Billion KRW	85.88%
2024 Q2	169.21 Billion KRW	71.08%
2023 Q2	51.45 Billion KRW	-10.4%
2023 FY	53.21 Billion KRW	25.73%
2023 Q4	53.21 Billion KRW	-16.34%
2023 Q3	63.6 Billion KRW	23.62%
2023 Q1	57.42 Billion KRW	35.69%
2022 Q1	33.88 Billion KRW	11.05%
2022 FY	42.32 Billion KRW	38.69%
2022 Q4	42.32 Billion KRW	-46.86%
2022 Q3	79.63 Billion KRW	30.81%
2022 Q2	60.88 Billion KRW	79.65%
2021 Q4	30.51 Billion KRW	-27.03%
2021 Q3	41.82 Billion KRW	122.83%
2021 Q2	18.76 Billion KRW	15.15%
2021 FY	30.51 Billion KRW	81.74%
2021 Q1	16.29 Billion KRW	-2.93%
2020 Q3	22.1 Billion KRW	-25.35%
2020 Q4	16.79 Billion KRW	-24.03%
2020 Q2	29.61 Billion KRW	0.0%
2020 FY	16.79 Billion KRW	0.0%

Peer Net Debt Comparison of EASY BIO,Inc.

Name	Net Debt	Net Debt Difference
HLB Co., Ltd.	-46.18 Billion KRW	215.216%
iNtRON Biotechnology, Inc.	-40.58 Billion KRW	231.11%
BINEX Co., Ltd.	45.34 Billion KRW	-17.34%
Bioneer Corporation	-3.9 Billion KRW	1461.654%
Anterogen.Co.,Ltd.	8.35 Billion KRW	-537.116%
MEDIPOST Co., Ltd.	14.81 Billion KRW	-259.183%
CrystalGenomics, Inc.	8.99 Billion USD	-491.761%
Helixmith Co., Ltd	-24.42 Billion KRW	317.846%
Chabiotech Co.,Ltd.	388.94 Billion KRW	86.319%
Medy-Tox Inc.	49.58 Billion KRW	-7.313%
Peptron, Inc.	4.86 Billion KRW	-992.927%
Amicogen, Inc.	125.26 Billion KRW	57.521%
Genexine, Inc.	61.39 Billion KRW	13.332%
HLB Therapeutics Co.,Ltd.	-13.68 Billion KRW	488.773%
LegoChem Biosciences, Inc.	-56.05 Billion KRW	194.928%
ALTEOGEN Inc.	53.56 Billion KRW	0.671%
PharmaResearch Co., Ltd.	-32.93 Billion KRW	261.546%
SillaJen, Inc.	-13.89 Billion KRW	483.042%
JETEMA, Co., Ltd.	84.27 Billion KRW	36.864%
OliX Pharmaceuticals,Inc	27.37 Billion KRW	-94.378%
Genomictree Inc.	-43.43 Billion KRW	222.506%
MedPacto, Inc.	-64 Billion KRW	183.141%
D&D Pharmatech	-7.5 Billion KRW	808.736%
GI Innovation, Inc.	-4.82 Billion KRW	1203.38%